Credit Suisse (SIX:CSGN) analyst Jailendra Singh maintained a Buy rating on Change Healthcare (NASDAQ:CHNG) Inc on Monday, setting a price target of $16, which is approximately 28.21% above the present share price of $12.48.
Singh expects Change Healthcare Inc to post earnings per share (EPS) of $0.35 for the second quarter of 2020.
The current consensus among 9 TipRanks analysts is for a Strong Buy rating of shares in Change Healthcare, with an average price target of $15.38.
The analysts price targets range from a high of $20 to a low of $12.
In its latest earnings report, released on 12/31/2019, the company reported a quarterly revenue of $0 and a net profit of -$1.12 million. The company's market cap is $3.79 billion.
According to TipRanks.com, Credit Suisse analyst Jailendra Singh is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 15.3% and a 86.67% success rate.
Change Healthcare, Inc. operates as a healthcare technology company. It offers software, analytics, network solutions, and technology-enabled services. The firm's products include ANSOS staff scheduling, HealthQx, hospital revenue cycle services, coding advisor, revenue performance advisor, and InterQual. The company was founded in 2007 and is headquartered in Alpharetta, GA.